|
autoimmune polyendocrine syndrome
|
DOID_14040 |
|
|
autoimmune polyendocrine syndrome type 1
|
DOID_0050167 |
|
|
contraceptive drug
|
CHEBI_49323 |
|
|
anti-HSV-2 agent
|
CHEBI_64954 |
|
|
anti-HSV agent
|
CHEBI_64952 |
|
|
female contraceptive drug
|
CHEBI_49324 |
|
|
EC 3.2.1.166 (heparanase) inhibitor
|
CHEBI_64955 |
|
|
oral contraceptive
|
CHEBI_49325 |
|
|
meiotic cell cycle
|
GO_0051321 |
|
|
synthetic oral contraceptive
|
CHEBI_49326 |
|
|
anti-HSV-1 agent
|
CHEBI_64953 |
|
|
inhalation anthrax
|
DOID_0050160 |
|
|
anthrax disease
|
DOID_7427 |
|
|
EC 3.4.21.39 (chymase) inhibitor
|
CHEBI_64957 |
|
|
meiotic M phase
|
GO_0051327 |
|
|
anti-HBV agent
|
CHEBI_64951 |
|
|
sebaceous carcinoma
|
DOID_4840 |
|
|
cutaneous lupus erythematosus
|
DOID_0050169 |
|
|
lupus erythematosus
|
DOID_8857 |
|
|
EC 1.1.3.9 (galactose oxidase) inhibitor
|
CHEBI_76920 |
|
